As a positive feedback loop between M2-TAMs and BC cells, the TAM-mediated secretion of the chemokine CCL2 contributes to the activation of the PI3K/Akt/mTOR pathway in BC cells, increasing their resistance to the anti-estrogen tamoxifen treatment. Here, MTOR is linked to breast cancer.